James A Cave (James Cave)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Mild Cognitive Impairment

Top Venues

Drug and therapeutics bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

James A Cave
Medicines and global warming: a complex problem. Drug and therapeutics bulletin (2024)
James A Cave
Medicines and global warming: a complex problem. Drug and therapeutics bulletin 62 (5) (2024)
James A Cave
Redaction at the heart of NICE appraisals . Drug and therapeutics bulletin (2023)
James A Cave
Changing the complexity of therapeutic monitoring. Drug and therapeutics bulletin 61 (12) (2023)
James A Cave, David Phizackerley
What does DTB stand for? Drug and therapeutics bulletin 61 (5) (2023)
James A Cave
Life begins at 60: DTB and the new challenges ahead. Drug and therapeutics bulletin 60 (4) (2022)
James A Cave
Stop advertising. Drug and therapeutics bulletin (2022)
David Phizackerley, James A Cave
From info-desert to info-demic: the role of independent drug bulletins. Drug and therapeutics bulletin 60 (5) (2022)
James A Cave
'Brain fog', MHT and dementia. Drug and therapeutics bulletin 60 (12) (2022)
James A Cave
What changes in the management of gout? Drug and therapeutics bulletin 60 (9) (2022)
James A Cave
Chloramphenicol eye drops, boron, infants and fertility. Drug and therapeutics bulletin 59 (7) (2021)
David Phizackerley, Joanna Girling, James A Cave
Desogestrel POM to P: for the few not the many? Drug and therapeutics bulletin 59 (10) (2021)
James A Cave, David Phizackerley
Molnupiravir: evidence by press release. Drug and therapeutics bulletin (2021)